|
Metropolis Healthcare, India’s second-largest pathology laboratory chain, has completed its fourth acquisition in the last 10 months, with Dr R S Patil’s Ambika Pathology Laboratory in Kolhapur joining the Metropolis network.
The NABL-accredited facility is among the region’s leading diagnostic providers and has been acquired through a Business Transfer Agreement. This marks a key milestone in Metropolis’ ‘String of Pearls’ strategy, which focuses on building strong regional clusters and expanding access to advanced diagnostics across India.
Established in 1995, Ambika Pathology Laboratory operates a central laboratory supported by 12 patient touchpoints and offers a comprehensive portfolio of tests. With nearly 75% of its revenue derived from B2C walk-in patients, the lab has a strong local connect making it a strategic addition to Metropolis’ Western Maharashtra cluster, where the company already operates 19 laboratories across Pune, Kolhapur, Sangli, Satara, Solapur, Nashik, and Ahmednagar, supported by more than 200 patient service centres and a growing franchise network.
Ameera Shah, promoter and executive chairperson, Metropolis Healthcare, said: “Maharashtra continues to be a key growth market for Metropolis, contributing nearly 40% of our total revenues. The acquisition of Ambika Pathology further strengthens our Western Maharashtra cluster and supports our ambition to make high-quality diagnostics accessible to more communities. We are committed to building the diagnostics network of the future, powered by technology, and connected with local healthcare ecosystems. Ambika’s regional presence make it a natural fit within our expanding B2C network.”
Surendran Chemmenkotil, managing director, Metropolis Healthcare, said: “Our network expansion, through both organic and inorganic growth, is a strategic step towards reshaping how diagnostics is delivered in India. Kolhapur is an important healthcare hub. Our focus remains on seamless integration, operational excellence, and digital innovation to build connected regional clusters that deliver world-class diagnostics and enable faster, more accurate insights for better patient outcomes.”
Dr. Rajendra Patil, founder and chief of lab, Ambika Pathology, Laboratory, said: “Partnering with Metropolis marks a significant milestone, as it brings global standards of science, technology, and operational excellence to our region. This collaboration will not only widen the scope of specialised tests available in Kolhapur but also create new opportunities for medical professionals and patients to benefit from advanced diagnostic innovations. We are confident that Ambika’s local legacy, combined with Metropolis’ scale and expertise, will set new benchmarks in diagnostic services for Western Maharashtra.”
|